Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Oil & Gas Exploration & Production
Buys27
Sells15
Buy $$3.51M
Sell $$3.77B
Ratio1:1074.11
Computer Hardware
Buys0
Sells617
Buy $$0.00
Sell $$976.49M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -3.0%
Software - Application
Buys65
Sells479
Buy $$64.78M
Sell $$809.12M
Ratio1:12.49
% Change vs. Prior
Ratio +139.7%Value +12.7%
Software - Infrastructure
Buys22
Sells725
Buy $$4.35M
Sell $$771.32M
Ratio1:177.49
% Change vs. Prior
Ratio -46.3%Value -39.2%
Medical - Instruments & Supplies
Buys4
Sells22
Buy $$1.33M
Sell $$733.42M
Ratio1:551.61
Semiconductors
Buys35
Sells198
Buy $$468.23K
Sell $$693.31M
Ratio1:1480.70
% Change vs. Prior
Ratio +3.2%Value -41.3%
Biotechnology
Buys162
Sells762
Buy $$170.21M
Sell $$463.00M
Ratio1:2.72
% Change vs. Prior
Ratio +170.1%Value -40.0%
Residential Construction
Buys45
Sells1
Buy $$595.29M
Sell $$108.79K
Ratio5471.86:1
Medical - Diagnostics & Research
Buys2
Sells179
Buy $$9.01K
Sell $$281.29M
Ratio1:31222.59
% Change vs. Prior
Ratio -99.3%Value -43.5%
Banks - Regional
Buys62
Sells118
Buy $$4.70M
Sell $$270.34M
Ratio1:57.50
% Change vs. Prior
Ratio -81.8%Value -69.4%
Internet Content & Information
Buys5
Sells204
Buy $$118.30K
Sell $$273.54M
Ratio1:2312.25
Information Technology Services
Buys26
Sells37
Buy $$9.14M
Sell $$249.72M
Ratio1:27.32
% Change vs. Prior
Ratio +54312.8%Value -70.6%
Asset Management
Buys127
Sells71
Buy $$215.65M
Sell $$31.52M
Ratio6.84:1
Specialty Business Services
Buys13
Sells6
Buy $$1.13M
Sell $$204.49M
Ratio1:181.67
Specialty Retail
Buys23
Sells208
Buy $$60.23M
Sell $$138.21M
Ratio1:2.29
% Change vs. Prior
Ratio +428.1%Value -71.7%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Sep 15, 2026
Sale
Shares
800
Price
$62.85
Total Value
$50.28K
Shares Held After
42,653
% of Holdings
1.8%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Sep 15, 2026
Sale
Shares
4,275
Price
$62.13
Total Value
$265.63K
Shares Held After
43,453
% of Holdings
9.0%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
400
Price
$65.31
Total Value
$26.12K
Shares Held After
87,508
% of Holdings
0.5%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
1,900
Price
$63.69
Total Value
$121.00K
Shares Held After
87,908
% of Holdings
2.1%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
300
Price
$65.31
Total Value
$19.59K
Shares Held After
105,389
% of Holdings
0.3%
Sep 15, 2026
Sale
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
432,886
% of Holdings
0.1%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
20,735
Price
$62.61
Total Value
$1.30M
Shares Held After
89,808
% of Holdings
18.8%
Sep 15, 2026
Sale
Shares
3,102
Price
$63.64
Total Value
$197.42K
Shares Held After
433,156
% of Holdings
0.7%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
1,400
Price
$63.69
Total Value
$89.17K
Shares Held After
105,689
% of Holdings
1.3%
Sep 15, 2026
Sale
Shares
28,796
Price
$62.66
Total Value
$1.80M
Shares Held After
436,258
% of Holdings
6.2%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
27,473
Price
$62.00
Total Value
$1.70M
Shares Held After
110,543
% of Holdings
19.9%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
13,874
Price
$62.63
Total Value
$868.96K
Shares Held After
107,089
% of Holdings
11.5%
Sep 15, 2026
Sale
Shares
63,498
Price
$61.99
Total Value
$3.94M
Shares Held After
465,054
% of Holdings
12.0%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
21,926
Price
$62.03
Total Value
$1.36M
Shares Held After
120,963
% of Holdings
15.3%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
98,197
% of Holdings
0.3%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
3,000
Price
$63.65
Total Value
$190.95K
Shares Held After
98,467
% of Holdings
3.0%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
29,021
Price
$62.66
Total Value
$1.82M
Shares Held After
101,467
% of Holdings
22.2%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
63,907
Price
$61.99
Total Value
$3.96M
Shares Held After
130,488
% of Holdings
32.9%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
1,431
Price
$65.31
Total Value
$93.46K
Shares Held After
117,066
% of Holdings
1.2%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
1,400
Price
$63.65
Total Value
$89.11K
Shares Held After
118,497
% of Holdings
1.2%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
27,421
Price
$62.59
Total Value
$1.72M
Shares Held After
119,897
% of Holdings
18.6%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
71,938
Price
$62.05
Total Value
$4.46M
Shares Held After
147,318
% of Holdings
32.8%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Sep 15, 2026
Sale
Shares
6,000
Price
$350.07
Total Value
$2.10M
Shares Held After
224,464
% of Holdings
2.6%
Sep 15, 2026
Sale
Shares
150,000
Price
$7.74
Total Value
$1.16M
Shares Held After
11,712,202
% of Holdings
1.3%

Ceribell, Inc. (CBLL)

Blumberg Scott — Chief Financial Officer
Sep 15, 2026
Sale
Shares
846
Price
$25.00
Total Value
$21.15K
Shares Held After
146,600
% of Holdings
0.6%

Ceribell, Inc. (CBLL)

Chao Xingjuan — Director
Sep 15, 2026
Sale
Shares
20,846
Price
$25.03
Total Value
$521.78K
Shares Held After
746,345
% of Holdings
2.7%
Sep 15, 2026
Sale
Shares
510
Price
$176.11
Total Value
$89.81K
Shares Held After
1,063,095
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
1,843
Price
$175.17
Total Value
$322.84K
Shares Held After
1,063,605
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
2,129
Price
$174.25
Total Value
$370.99K
Shares Held After
1,065,448
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
2,319
Price
$173.05
Total Value
$401.31K
Shares Held After
1,067,577
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
3,990
Price
$172.24
Total Value
$687.22K
Shares Held After
1,069,896
% of Holdings
0.4%
Sep 15, 2026
Sale
Shares
3,901
Price
$171.09
Total Value
$667.41K
Shares Held After
1,073,886
% of Holdings
0.4%
Sep 15, 2026
Sale
Shares
1,308
Price
$170.26
Total Value
$222.70K
Shares Held After
1,077,787
% of Holdings
0.1%

Paysign, Inc. (PAYS)

Herman Joan M — Director
Sep 15, 2026
Sale
Shares
21,004
Price
$12.38
Total Value
$260.07K
Shares Held After
648,321
% of Holdings
3.1%
Sep 15, 2026
Sale
Shares
420
Price
$48.89
Total Value
$20.53K
Shares Held After
175,653
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
3,380
Price
$48.17
Total Value
$162.81K
Shares Held After
176,073
% of Holdings
1.9%
Sep 15, 2026
Sale
Shares
2,700
Price
$47.24
Total Value
$127.55K
Shares Held After
179,453
% of Holdings
1.5%
Sep 15, 2026
Sale
Shares
1,000
Price
$48.50
Total Value
$48.50K
Shares Held After
61,200
% of Holdings
1.6%

Genius Sports Ltd (GENI)

Locke Mark — Director
Sep 15, 2026
Sale
Shares
477,449
Price
$6.58
Total Value
$3.14M
Shares Held After
19,697,767
% of Holdings
2.4%

Grab Holdings Ltd (GRAB)

Oey Peter Henry — Chief Financial Officer
Sep 15, 2026
Sale
Shares
50,000
Price
$2.90
Total Value
$145.19K
Shares Held After
6,803,470
% of Holdings
0.7%

Legence Corp. (LGN)

Le Bris Philippe — Chief Accounting Officer
Sep 15, 2026
Sale
Shares
4,196
Price
$54.06
Total Value
$226.84K
Shares Held After
6,148
% of Holdings
40.6%

Grab Holdings Ltd (GRAB)

Kandal Philipp Wolfgang Josef — Chief Product Officer
Sep 15, 2026
Sale
Shares
30,000
Price
$3.08
Total Value
$92.40K
Shares Held After
3,958,735
% of Holdings
0.8%
Sep 15, 2026
Sale
Shares
786
Price
$243.45
Total Value
$191.35K
Shares Held After
7,746,019
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
1,429
Price
$242.53
Total Value
$346.58K
Shares Held After
7,746,805
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
1,675
Price
$241.90
Total Value
$405.18K
Shares Held After
7,748,234
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
1,049
Price
$240.67
Total Value
$252.46K
Shares Held After
7,749,909
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
569
Price
$239.68
Total Value
$136.38K
Shares Held After
7,750,958
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
480
Price
$238.31
Total Value
$114.39K
Shares Held After
7,751,527
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
640
Price
$237.38
Total Value
$151.92K
Shares Held After
7,752,007
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
1,088
Price
$236.35
Total Value
$257.15K
Shares Held After
7,752,647
% of Holdings
0.0%
Version: v26.10.6